What are the common side effects of lurbinectedin?

What side effects do patients report most often?
Lurbinectedin frequently causes low blood-cell counts, especially neutropenia, anemia, and thrombocytopenia. Fatigue, nausea, vomiting, constipation, and decreased appetite are also common.

What happens if white blood cells drop too low?
Severe neutropenia can raise infection risk. Doctors usually monitor blood counts before each dose and may delay or reduce treatment if counts fall below safe levels.

Do gastrointestinal effects need special management?
Nausea and vomiting can be controlled with standard antiemetics given before and after infusion. Constipation may require stool softeners or dietary changes.

How do liver-enzyme changes fit in?
Elevations in ALT, AST, and alkaline phosphatase occur in many patients. Most shifts are mild, but doctors check liver function before each cycle.

Are there any rare but serious reactions?
Rhabdomyolysis and severe hypersensitivity reactions have been noted. Patients should report unexplained muscle pain or swelling promptly.

Can side effects differ by dose or schedule?
Higher doses and shorter intervals increase the chance of blood-count problems and fatigue. The approved regimen is 3.2 mg/m² every 21 days.

When does the patent on lurbinectedin expire?
According to DrugPatentWatch.com, U.S. regulatory exclusivity for the current indication runs until 2033, with several patents extending further into the 2030s.